Network origin in Rita Dege first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
21
| Extinct | Pharmaceuticals: Major | 21 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rita Dege via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| TRANSGENE | Biotechnology | Director/Board Member | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PHOTOCURE ASA | Medical Specialties | Director/Board Member Chairman | |
| MORPHOSYS AG | Biotechnology | General Counsel Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| University of Toronto | College/University | Doctorate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member | |
| University of Oslo | College/University | Doctorate Degree Graduate Degree | |
| University of Tromso | College/University | Undergraduate Degree | |
NatWest Markets Plc
 NatWest Markets Plc Regional BanksFinance NatWest Markets Plc engages in the provision of banking and financial services. It operates through the NatWest Markets and Central Items and Other segments. The NatWest Markets segment offers trading, risk management, and financing solutions. The Central Items and Other segment includes corporate functions and other activity of the firm. The company was founded on October 31, 1984 and is headquartered in London, the United Kingdom. | Regional Banks | Director/Board Member | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
| University of Nice Sophia Antipolis | College/University | Doctorate Degree | |
| MOLECULAR PARTNERS AG | Biotechnology | Chief Tech/Sci/R&D Officer | |
BDO Noraudit ASA
 BDO Noraudit ASA Miscellaneous Commercial ServicesCommercial Services BDO Noraudit ASA provides accounting services. The private company is based in Oslo, Norway. | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of Parma | College/University | Undergraduate Degree | |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | ||
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Amgen Dompé SpA
 Amgen Dompé SpA Miscellaneous Commercial ServicesCommercial Services Amgen Dompé SpA wholesales pharmaceutical products. The company is headquartered in Milan, Italy. | Miscellaneous Commercial Services | Chief Executive Officer | |
Amgen SAS
 Amgen SAS Medical DistributorsDistribution Services Amgen SAS manufactures and distributes medicines. It specializes in biopharmaceutical products for diseases in the fields of oncology, cardiology, rheumatology, and nephrology. The company was founded in 1990 and is headquartered in Boulogne-Billancourt, France. | Medical Distributors | Chief Executive Officer | |
| BERGENBIO ASA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Synergie Lyon Cancer
 Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | President | |
| European Organisation for Research & Treatment of Cancer | Director/Board Member | ||
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
| MEDINCELL S.A. | Pharmaceuticals: Major | Director/Board Member | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
| SDA Bocconi School of Management | College/University | Masters Business Admin | |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Chief Executive Officer Founder Director/Board Member | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Institut de Recherches Internationales Servier
 Institut de Recherches Internationales Servier Miscellaneous Commercial ServicesCommercial Services Part of Servier SAS, Institut de Recherches Internationales Servier is a French company that provides scientific research and development services. The company is based in Suresnes, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Biotechnology | Chairman | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
PinCell Srl
 PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | Biotechnology | Chairman | |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Chief Executive Officer | |
| VIRACTA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 19 |
| France | 10 |
| Norway | 8 |
| Switzerland | 5 |
| Italy | 5 |
Sectoral
| Health Technology | 35 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Finance | 3 |
| Process Industries | 2 |
Operational
| Director/Board Member | 85 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 31 |
| Chief Executive Officer | 29 |
| Chairman | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Jan Hendrik Egberts | 33 |
| Jean Bizzari | 24 |
| Ludvik Sandnes | 22 |
| Eduardo Bravo Fernández de Araoz | 19 |
| Renee Tannenbaum | 16 |
| Joanna Horobin | 15 |
| Tone Kvåle | 13 |
| Lisa Rojkjaer | 12 |
| Rainer Boehm | 12 |
| Dominic Smethurst | 11 |
| Luigi Costa | 10 |
| Roy Hartvig Larsen | 9 |
| Jan Alan Alfheim | 9 |
| Cristina Oliva | 7 |
| Lars Nieba | 7 |
- Stock Market
- Insiders
- Rita Dege
- Company connections
